Your heartHealthy livingFor professionalsResearchHow you can helpAbout us

Inotropes in cardiogenic shock

Research directory


Inotropes in cardiogenic shock

Associate Professor Dion Stub, Monash University

2020 Vanguard Grant

Years funded: 2021-2023

Shock is one of the most challenging clinical management scenarios experienced by clinicians, whether in the pre-hospital or hospital settings. It is a syndrome characterised by an imbalance of oxygen delivery and demand particularly in vital organs, with circulatory and septic shock being most common. Shock is a common clinical problem present in one third of patients admitted to an intensive care unit (ICU). Despite the advances in our ability to support these patients with early identification and treatment, the morbidity and mortality of shocked patients remains unacceptably high. In a contemporary international trial examining patients with shock, 50% of patients died despite best therapy. The early phase management of patients with shock may require medications to improve low blood pressure and cardiac output (inotropes and/or vasopressors). The majority of local and international paramedics commonly use adrenaline as a first line agent to treat patients in shock, despite data highlighting potential benefits of an alternative agent noradrenaline.

The PANDA trial will be the first study in the pre-hospital setting to critically evaluate the initial management of patients with shock. The study will be a multi-centre randomized controlled trial, of adrenaline versus Noradrenaline in patients with Shock as diagnosed by paramedics in the pre-hospital setting. The investigator are international leaders in conducting clinical trials in the pre-hospital environment and will randomize 850 patients over 2 years, with as evidenced by the investigators previous trials, the very real potential to impact local and international guidelines.

You might also be interested in...

Dion Stub in light blue scrubs smiling at the camera
Q&A with Associate Professor Dion Stub

Looking at how patients are treated when their heart stops beating, and how a better job can be done of getting more people through that trauma.

Manual pressure augmentation in defibrillation of ventricular arrhythmias (AUGMENT RCT)

World first randomised controlled trial of cardiac arrest patients that compares MPA with standard ('hands off') defibrillation

Professor giving a pose for the camera
Associate Professor Dion Stub

Pre-hospital point-of-care troponin and risk assessment in chest pain patients

Last updated12 July 2021